Richard Quinton has been a Consultant Endocrinologist at the Royal Victoria Infirmary. Newcastle-upon-Tyne since 1999 and Senior Lecturer at the Newcastle Universitys Institute of Genetic Medicine.
He graduated from Cambridge University in 1988. Following core medical training at St Bartholomews Hospital London and Erasmus University Hospital Rotterdam. he trained in general and reproductive endocrinology at University College London Hospitals. gaining his CCST in 1998. along with a lifelong interest in transitional and reproductive endocrinology and andrology.
He has been active in the field of hypogonadism research since 1993 and was awarded the Ralph Noble Prize by Cambridge University for his MD thesis on Kallmann syndrome in 2001. He has published nearly 200 articles. including several in NEJM. JCI. PNAS & BMJ. As well as collaborating with molecular geneticists to identify key genes involved in the neuroendocrine control of human reproduction. his emphasis on careful patient phenotyping and longitudinal follow-up has resulted in novel clinical observations that have changed perceptions of the plasticity of the human GnRH pulse-generator and its resilience in the face of both genetic and environmental insults.
Dr. Quinton has long been an active supporter of patient involvement and self-help groups. including kallmanns.org. Klinefelter Syndrome UK. Turner syndrome UK and was a founder member (currently Vice Chair) of the gnrh.eu network of clinicians. researchers. educators and patients. funded by the EU as part of its Collaboration in Science & Technology programme. which has begun to shape directions of travel for collaborative research. patient education and patient access to best care across Europe in the field of central hypogonadotrophic hypogonadism.
For the past 5 years. he has led teaching for the Reproduction & Gonads strand of the Society for Endocrinologys (SfE) annual Clinical Update programme. He recently redrafted the SfEs guidance on testosterone treatment of older men and is currently helping to formulate SFEs guidance on the diagnosis and treatment of male hypogonadism.